These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6157362)

  • 1. Type II interferon induction and passive transfer depress the murine cytochrome P-450 drug metabolism system.
    Sonnenfeld G; Harned CL; Thaniyavarn S; Huff T; Mandel AD; Nerland DE
    Antimicrob Agents Chemother; 1980 Jun; 17(6):969-72. PubMed ID: 6157362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of interferon on drug metabolism.
    Sonnenfeld G; Harned CL; Nerland DE
    Tex Rep Biol Med; 1981-1982; 41():363-9. PubMed ID: 6817439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of passive transfer and induction of gamma (type II immune) interferon preparations on the metabolism of diphenylhydantoin by murine cytochrome P-450.
    Harned CL; Nerland DE; Sonnenfeld G
    J Interferon Res; 1982; 2(1):5-10. PubMed ID: 6180105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interferon on murine cytochrome P-450: effect of partially purified antigen-specific interferon-gamma.
    Smith PK; Nerland DE; Sonnenfeld G
    J Interferon Res; 1983; 3(2):219-22. PubMed ID: 6409972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and II interferons and migration inhibitory factor: production in Mycobacterium bovis BCG-infected mice desensitized with old tuberculin or lipopolysaccharide.
    Youngner JS; Salvin SB
    Infect Immun; 1978 Mar; 19(3):912-4. PubMed ID: 346489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
    Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
    Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro production and cellular origin of murine type II interferon.
    Sonnenfeld G; Mandel AD; Merigan TC
    Immunology; 1979 Apr; 36(4):883-90. PubMed ID: 374263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of cytochrome b5 into rat liver microsomal membranes. Impairment of cytochrome P-450-dependent mixed function oxidase activity.
    Gibson GG; Clarke SE
    Biochem Pharmacol; 1986 Dec; 35(24):4431-6. PubMed ID: 3790162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thymosin fraction 5 on the production of murine gamma interferon.
    Sonnenfeld G; Mansfield JM
    Immunopharmacology; 1982 Feb; 4(1):87-93. PubMed ID: 6174479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of alpha and beta interferons during the hyporeactive state of gamma interferon by Mycobacterium bovis BCG cell wall fraction in Mycobacterium bovis BCG-sensitized mice.
    Nakane A; Minagawa T
    Infect Immun; 1982 Jun; 36(3):966-70. PubMed ID: 6178694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of rat hepatic CYP3A1 induction by the interferon inducer polyinosinic acid-polycytidylic acid (polyic).
    Delaporte E; Cribb AE; Renton KW
    Drug Metab Dispos; 1993; 21(3):520-3. PubMed ID: 7686458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic aminopyrine N-demethylase system: further studies of assay procedure.
    Matsubara T; Touchi A; Tochino Y
    Jpn J Pharmacol; 1977 Feb; 27(1):127-36. PubMed ID: 559190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic aminopyrine N-demethylase system: effect of cyanide on microsomal N-demethylase activity.
    Matsubara T; Touchi A
    Jpn J Pharmacol; 1977 Oct; 27(5):701-8. PubMed ID: 563483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active centers of microsomal cytochrome P-450 determined with metyrapone by mutural depletion system kinetics.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):39-52. PubMed ID: 4267597
    [No Abstract]   [Full Text] [Related]  

  • 15. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of certain vitamin deficiencies on hepatic drug metabolism.
    Zannoni VG; Sato PH
    Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular source of interferons in the circulation of mice with delayed hypersensitivity.
    Sonnenfeld G; Salvin SB; Youngner JS
    Infect Immun; 1977 Nov; 18(2):283-90. PubMed ID: 336540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of effect of interferon on drug metabolism.
    Mannering GJ
    Methods Enzymol; 1986; 119():718-25. PubMed ID: 2429164
    [No Abstract]   [Full Text] [Related]  

  • 19. A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration.
    Muhoberac BB; Hanew T; Halter S; Schenker S
    Biochem Pharmacol; 1989 Nov; 38(22):4103-13. PubMed ID: 2512932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-competitive and competitive inhibition of mixed function oxidase in rat liver microsomes by metyrapone.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):27-38. PubMed ID: 4350469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.